ZNTL EPS Estimates
Zentalis Pharmaceuticals, Inc.
$2.51
-$0.04(-1.57%)
34
Overall
60
Value
18
Tech
26
Quality
Market Cap
$241.40M
Volume
1.27M
52W Range
$1.21 - $6.95
Target Price
$7.30
ZNTL EPS estimates: the consensus estimate for Zentalis Pharmaceuticals, Inc.'s current fiscal year is -$2.11 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ZNTL EPS Estimates
- EPS estimate, current quarter
- $-0.58
- EPS estimate, next quarter
- $-0.58
- EPS estimate, current year
- $-2.11
- EPS estimate, next year
- $-2.21
- EPS growth, 3-year
- +24.74%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.91 |
| 2024 | $-2.33 |
| 2023 | $-4.47 |
| 2022 | $-4.48 |
| 2021 | $-3.72 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZNTL | $2.51 | -1.6% | 1.27M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Zentalis Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW